• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 MARKSMAN; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 MARKSMAN; CATHETER, CONTINUOUS FLUSH Back to Search Results
Model Number UNK-NV-MARKSMAN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Muscle Weakness (1967); Thromboembolism (2654)
Event Date 02/15/2022
Event Type  Injury  
Event Description
Pabst lm, zyck sa, youssef p.Successful thrombectomy in a pediatric patient with large vessel occlusion and covid-19 related multisystem inflammatory syndrome.Interventional neuroradiology: journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.2023;29(2):214-216.Doi:10.1177/15910199221080873 medtronic literature review found a report of clot migration in association with the solitaire stent and marksman microcatheter.The purpose of this article was to report the first known case of a child with multisystem inflammatory syndrome in children (mis-c) complicated by an acute ischemic stroke with right m1 occlusion and large penumbra who underwent thrombectomy with tici 3 recanalization.It was reported that a previously healthy school-age child was admitted to the pediatric intensive care unit (picu) with mis-c requiring vasoactive and respiratory support.Presenting symptoms included fever, abdominal pain, sore throat, myalgias, emesis and conjunctival injection with laboratory evidence of multi-organ dysfunction.On the third day after admission, the child developed left hemiplegia, left facial droop, homonymous hemianopsia and dysarthria with a pediatric nih stroke scale (pednihss) of  16.Imaging found an acute right lenticulostriate infarct and occlusion of the right m1 segment of the middle cerebral artery.Under general anesthesia, right femoral access was obtained.A 6 french arrow-flex 65-centimeter sheath (teleflex) was placed.The right internal carotid artery was selectively catheterized with a 5 french angled glide catheter over a 0.035 inch glidewire (terumo).The shuttle was advanced over the select catheter to the distal cervical right internal carotid artery.Right internal carotid artery angiography was p erformed, which demonstrated a right m1 occlusion.A catalyst-6 distal access catheter was advanced co-axially with a marksman 0.027 inch microcatheter and 0.014 inch wire.The microcatheter and 0.014 inch wire were used to cross the lesion and the distal access c atheter was advanced to the proximal face of the lesion.A solitaire 4 × 40 mm stent retriever was deployed across the lesion.The microcatheter was removed and the stent retriever was left open for four minutes under continuous aspiration.The stent retriever was then retrieved under continuous aspiration.Control angiography after the first pass showed proximal migration of the clot to the more proximal m1 segment.The same technique was repeated for a second pass using a solitaire 6 × 40 mm stent retriever.Control right internal carotid artery angiography was performed and demonstrated tici3 revascularization.There was no radiologic evidence of vasculitis.Follow-up imaging 48 h after thrombectomy showed stable size of the known infarction and four small areas of micro-infarction in right cortical white matter.The child was transferred to the inpatient rehabilitation ward on post stroke day seven, where he completed two weeks of intensive therapy.At time of discharge, he was walking independently and had a pednihss of 1 for mild left arm weakness.At two month follow-up in the pediatric stroke clinic, he reported a full return to school without any cognitive or physical limitations.The child continued to get weekly physical therapy for mild left-sided weakness and exam demonstrated a stable pednihss of 1 for left arm weakness.The article does not state any technical issues during use of the solitaire the following intra- or post-procedural outcomes were noted: -proximal migration of the clot -mild left arm weakness.
 
Manufacturer Narrative
Pabst lm, zyck sa, youssef p.Successful thrombectomy in a pediatric patient with large vessel occlusion and covid-19 related multisystem inflammatory syndrome.Interventional neuroradiology: journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.2023;29(2):214-216.Doi:10.1177/15910199221080873 b.3.Please note that this date is based off of the date of publication of the article as the event dates were not provided in the published literature see related report #2029214-2023-02466.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MARKSMAN
Type of Device
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key18388733
MDR Text Key331308835
Report Number2029214-2023-02467
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-NV-MARKSMAN
Device Catalogue NumberUNK-NV-MARKSMAN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/05/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexMale
-
-